MULTICENTER COMPARISON OF IN-VITRO ACTIVITIES OF FK-037, CEFEPIME, CEFTRIAXONE, CEFTAZIDIME, AND CEFUROXIME

被引：41
|
作者：
WASHINGTON, JA
JONES, RN
GERLACH, EH
MURRAY, PR
ALLEN, SD
KNAPP, CC
机构：
[1] UNIV IOWA HOSP & CLIN,IOWA CITY,IA 52242
[2] ST FRANCIS REG MED CTR,WICHITA,KS 67214
[3] WASHINGTON UNIV,MED CTR,ST LOUIS,MO 63130
[4] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46223
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1993年 / 37卷 / 08期
关键词：
D O I：
10.1128/AAC.37.8.1696
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In a multicenter study, the MICs of FK-037 for 90% of the strains tested (MIC90s) were less-than-or-equal-to 1 mug/ml for members of the family Enterobacteriaceae other than Citrobacter freundii, Enterobacter spp., and Serratia marcescens. Activity against Pseudomonas aeruginosa was variable, with a MIC50 and a MIC90 of 4 and 32 mug/ml, respectively. Relative to cefepime, however, FK-037 was less active against ceftazidime-resistant isolates of Enterobacter cloacae. The MIC90 of FK-037 for methicillin-resistant staphylococci was > 16 mug/ml.
引用
收藏
页码：1696 / 1700
页数：5
相关论文
共 50 条
  • [31] Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia:: A prospective, randomized, multicenter study
    Erman, M
    Akova, M
    Akan, H
    Korten, V
    Ferhanoglu, B
    Köksal, I
    Çetinkaya, Y
    Uzun, Ö
    Ünal, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (11) : 827 - 831
  • [32] IN-VITRO ANTIBACTERIAL ACTIVITY OF FK037, A NEW PARENTERAL BROAD-SPECTRUM CEPHALOSPORIN, AGAINST RECENT CLINICAL ISOLATES IN THE FIELDS OF OBSTETRICS AND GYNECOLOGY
    MIKAMO, H
    IZUMI, K
    ITO, K
    KATOH, N
    WATANABE, K
    UENO, K
    TAMAYA, T
    CHEMOTHERAPY, 1994, 40 (03) : 161 - 166
  • [33] IN-VITRO ACTIVITIES OF CIPROFLOXACIN, CEFOTAXIME, CEFTRIAXONE, CHLORAMPHENICOL, AND RIFAMPIN AGAINST FULLY SUSCEPTIBLE AND MODERATELY PENICILLIN-RESISTANT NEISSERIA-MENINGITIDIS
    BLONDEAU, JM
    YASCHUK, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2577 - 2579
  • [34] IN-VITRO EXTRACELLULAR AND INTRACELLULAR ACTIVITIES OF CLAVULANIC ACID AND THOSE OF PIPERACILLIN AND CEFTRIAXONE ALONE AND IN COMBINATION WITH TAZOBACTAM AGAINST CLINICAL ISOLATES OF LEGIONELLA SPECIES
    EDELSTEIN, PH
    EDELSTEIN, MAC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) : 200 - 204
  • [35] COMPARISON OF LEVELS OF ALDEHYDE OXIDASE WITH CYTOCHROME-P450 ACTIVITIES IN HUMAN LIVER IN-VITRO
    RODRIGUES, AD
    BIOCHEMICAL PHARMACOLOGY, 1994, 48 (01) : 197 - 200
  • [36] Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020
    Jean, Shio-Shin
    Ko, Wen-Chien
    Lu, Min-Chi
    Lee, Wen-Sen
    Hsueh, Po-Ren
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 941 - 953
  • [37] IN-VITRO ACTIVITIES OF CEFEPIME AGAINST ENTEROBACTER-CLOACAE, SERRATIA-MARCESCENS, PSEUDOMONAS-AERUGINOSA AND OTHER AEROBIC GRAM-NEGATIVE BACILLI
    CHONG, YS
    LEE, KW
    KWON, OH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 : 21 - 29
  • [38] In-vitro Susceptibility Testing Methods for Ceftazidime-avibactam against Carbapenem-resistant Enterobacterales: Comparison with Reference Broth Microdilution Method
    Sharma, Bhawna
    Sreenivasan, Priya
    Angrup, Archana
    Kaur, Satinder
    Rana, Sudesh
    Kundu, Jyoti
    Biswal, Manisha
    Ray, Pallab
    CURRENT DRUG SAFETY, 2023, 18 (04) : 563 - 570
  • [39] In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
    Palwe, Snehal
    Bakthavatchalam, Yamuna Devi
    Khobragadea, Kshama
    Kharat, Arun S.
    Walia, Kamini
    Veeraraghavan, Balaji
    ANTIBIOTICS-BASEL, 2021, 10 (11):
  • [40] In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020
    Lee, Yu-Lin
    Ko, Wen-Chien
    Lee, Wen-Sen
    Lu, Po-Liang
    Chen, Yen-Hsu
    Cheng, Shu-Hsing
    Lu, Min-Chi
    Lin, Chi-Ying
    Wu, Ting-Shu
    Yen, Muh-Yong
    Wang, Lih-Shinn
    Liu, Chang-Pan
    Shao, Pei-Lan
    Shi, Zhi-Yuan
    Chen, Yao-Shen
    Wang, Fu-Der
    Tseng, Shu-Hui
    Lin, Chao-Nan
    Chen, Yu-Hui
    Sheng, Wang-Huei
    Lee, Chun-Ming
    Tang, Hung-Jen
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (03)
12345